Matt Fisher

Matt Fisher is an accomplished accounting professional with extensive experience in the legal sector. Currently serving as a 3E Administrator at Sterne, Kessler, Goldstein & Fox since March 2014, notable achievements include instituting a programmatic audit trail using OQL, creating processes for Payroll journal entries, and enhancing matter planning through module installation and updates. Prior roles include Special Projects Accountant, Western Regional Billing Manager at K&L Gates, LLP, and Accounting Manager at Preston Gates Ellis & Rouvelas Meeds LLP, where Fisher demonstrated expertise in billing, workflow optimization, and training staff on new systems. Matt Fisher began their career at Biltmore Securities as an Office Manager, contributing to back-office management and trading operations. Educational credentials include a BS in Mathematics from Virginia Tech and further studies at The George Washington University School of Business.

Location

Chesapeake Beach, United States

Links


Org chart

No direct reports

Teams


Offices


Sterne, Kessler, Goldstein & Fox

Sterne, Kessler, Goldstein & Fox is an intellectual property specialty firm dedicated exclusively to the protection, transfer and enforcement of IP rights for their clients. Their team of attorneys, registered patent agents, students and technical specialists include some of the country's most respected practitioners of intellectuall property law. Most of their professionals hold an advanced-level degree, including more than 50 with a doctorate in science or engineering. Teaming with their IP professionals is a dynamic and extraordinarily capable team of managers and staff in a work environment with robust technical platforms, protocols and systems for the highest levels of efficiency in delivering a full suite of services to clients.Their client base includes developing and established companies, venture capital firms, individual entrepreneurs and universities — from bleeding-edge technology fields, like carbon footprint technologies, pharmacogenomics, nanomedicine and biofuels to next-generation electronics and other consumer products.